Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX Syndrome.
暂无分享,去创建一个
[1] J. Hauber,et al. Improving Lentiviral Transduction of CD34+ Hematopoietic Stem and Progenitor Cells. , 2018, Human gene therapy methods.
[2] F. Rieux-Laucat,et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study , 2017, The Journal of allergy and clinical immunology.
[3] L. Naldini,et al. Ectopic FOXP3 Expression Preserves Primitive Features Of Human Hematopoietic Stem Cells While Impairing Functional T Cell Differentiation , 2017, Scientific Reports.
[4] David Gray,et al. Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned. , 2017, Cell stem cell.
[5] P. Zhu,et al. Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis , 2016, Scientific Reports.
[6] Harri Lähdesmäki,et al. Control of Foxp3 stability through modulation of TET activity , 2016, The Journal of experimental medicine.
[7] Michael L Kaufman,et al. Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy , 2015, Stem cells.
[8] C. Benner,et al. Function of a Foxp3 cis-Element in Protecting Regulatory T Cell Identity , 2014, Cell.
[9] M. Wunderlich,et al. OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues. , 2014, Blood.
[10] L. Naldini,et al. CD4+ T Cells from IPEX Patients Convert into Functional and Stable Regulatory T Cells by FOXP3 Gene Transfer , 2013, Science Translational Medicine.
[11] R. Geffers,et al. Active Demethylation of the Foxp3 Locus Leads to the Generation of Stable Regulatory T Cells within the Thymus , 2013, The Journal of Immunology.
[12] S. Shurtleff,et al. Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX. , 2011, Clinical immunology.
[13] Aaron R Cooper,et al. Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration. , 2011, Journal of virological methods.
[14] A. Rudensky,et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate , 2010, Nature.
[15] S. Ziegler,et al. CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice. , 2009, Blood.
[16] T. Lion,et al. Selective engraftment of donor CD4+25high FOXP3-positive T cells in IPEX syndrome after nonmyeloablative hematopoietic stem cell transplantation. , 2009, Blood.
[17] James L Riley,et al. Human T regulatory cell therapy: take a billion or so and call me in the morning. , 2009, Immunity.
[18] A. Logan,et al. Factors influencing the titer and infectivity of lentiviral vectors. , 2004, Human gene therapy.
[19] F. Ramsdell,et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.
[20] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[21] M. Mortrud,et al. The Amount of Scurfin Protein Determines Peripheral T Cell Number and Responsiveness1 , 2001, The Journal of Immunology.
[22] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[23] J. Casanova,et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.
[24] D. Galas,et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.
[25] D. Trono,et al. A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.